 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| ETX-810 / Eliem Therap
P2a data: $ELYM Phase 2a trial investigating ETX-810 for the treatment of lumbosacral radicular pain (LSRP) did not meet its primary endpoint (Twitter) - Aug 2, 2022
- ||| ETX-810 / Eliem Therap
Trial completion: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain (clinicaltrials.gov) - Jun 30, 2022
P2, N=148, Completed, Sponsor: Eliem Therapeutics (UK) Ltd.
Recruiting --> Completed
- || ETX-155 / Eliem Therap, ETX-810 / Eliem Therap
Clinical: $ELYM Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs https://t.co/P8JJF3V3Mg (Twitter) - Apr 25, 2022
- ||| ETX-810 / Eliem Therap
Trial completion: Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain (clinicaltrials.gov) - Mar 24, 2022
P2, N=167, Completed, Sponsor: Eliem Therapeutics (UK) Ltd.
Recruiting --> Completed Recruiting --> Completed
- || ETX-810 / Eliem Therap
Trial completion date, Trial primary completion date: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain (clinicaltrials.gov) - Jan 19, 2022
P2, N=122, Recruiting, Sponsor: Eliem Therapeutics (UK) Ltd.
Recruiting --> Completed Trial completion date: Oct 2021 --> Jul 2022 | Trial primary completion date: Oct 2021 --> Jul 2022
- | ETX-810 / Eliem Therap
Trial completion date: Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain (clinicaltrials.gov) - Nov 3, 2021
P2, N=162, Recruiting, Sponsor: Eliem Therapeutics (UK) Ltd.
Trial completion date: Oct 2021 --> Jul 2022 | Trial primary completion date: Oct 2021 --> Jul 2022 Trial completion date: Oct 2021 --> Mar 2022
- |||| ETX-810 / Eliem Therap
New P2 trial: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain (clinicaltrials.gov) - Mar 2, 2021
P2, N=122, Recruiting, Sponsor: Eliem Therapeutics (UK) Ltd.
- | ETX-810 / Eliem Therap
New P2 trial: Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain (clinicaltrials.gov) - Dec 29, 2020
P2, N=162, Recruiting, Sponsor: Eliem Therapeutics (UK) Ltd.